MULLENNIX STEPHEN (COO) sold 5.9% of their position (612.00 shares) of UROGEN PHARMA LTD. on the open market
Open‑market sale worth $17.2K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 2/18/2020ACC: 0001209191-20-009943
-612.00
Net shares
Net seller
$17.2K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
1.76K acquired · 2.37K disposed
Non-Derivative Transactions2
Ordinary Shares
Direct
Shares
+1.76K
Price / share
—
Trade value
—
% of position
20.3%
2/14/2020
8.66K→10.42K
Ordinary Shares
Direct
Shares
−612.00
Price / share
$28.04
Trade value
$17.16K
% of position
5.9%
2/14/2020
10.42K→9.81K
Total
Net shares
+1.15K
Net value
-$17.16K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares Direct | 2/14/2020 | M · Option Exercise | +1.76K | — | — | 20.3% | 8.66K | 10.42K |
| Ordinary Shares Direct | 2/14/2020 | S · Sale | −612.00 | $28.04 | $17.16K | 5.9% | 10.42K | 9.81K |
| Total | +1.15K | -$17.16K | ||||||
Derivative Transactions1
Restricted Stock Units
Direct
Converts to
Ordinary Shares
1.76K shares
Shares
−1.76K
Strike price
Held after
7.04K
Exercisable
—
2/14/2020
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Restricted Stock Units Direct | Ordinary Shares1.76K shares | 2/14/2020 | M · Option Exercise | −1.76K | — | 7.04K |